S19 An update on therapeutic strategies and clinical trials in dementia
Date: Tuesday 21 June
Time: 15.40 - 16.55
Stream: New science
This session will review potential treatment strategies for dementia based on inflammation, protein handling, glucose metabolism and tau phosphorylation and clinical trials which target these.
Chair: Professor John O'Brien, University of Cambridge
Inflammation as a therapeutic target in alzheimer's disease
Dr Vanessa Raymont, University of Oxford
Lithium and other inhibitors of tau phosphorylation
Dr Ross Dunne, University of Manchester
Protein production, degradation and glucose metabolism
Dr Ben Underwood, University of CambridgeSpeakers
Please email congress@rcpsych.ac.uk or call 020 8618 4120 with any enquiries.